Dr. Kenneth W Dawes
Claim this profileDawes Fretzin Clinical Research Group, LLC
Studies Plaque Psoriasis
Studies Psoriasis
10 reported clinical trials
15 drugs studied
Affiliated Hospitals
Clinical Trials Kenneth W Dawes is currently running
Baricitinib
for Pediatric Hair Loss
This trial is testing baricitinib, a medication that may help treat severe hair loss. It targets children aged 6 to less than 18 years who have significant hair loss. The medication works by reducing the immune system's activity that causes hair loss.
Recruiting1 award Phase 35 criteria
HyBryte Cream
for Cutaneous T-Cell Lymphoma
To evaluate the use of HyBryte, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).
Recruiting1 award Phase 31 criteria
More about Kenneth W Dawes
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kenneth W Dawes has experience with
- Orticumab
- Vehicle Gel
- NFX-179 Gel
- Daxdilimab
- HyBryte
- Lebrikizumab
Breakdown of trials Kenneth W Dawes has run
Plaque Psoriasis
Psoriasis
Burn Injury
Alopecia Areata
Atopic Dermatitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Kenneth W Dawes specialize in?
Is Kenneth W Dawes currently recruiting for clinical trials?
Are there any treatments that Kenneth W Dawes has studied deeply?
What is the best way to schedule an appointment with Kenneth W Dawes?
What is the office address of Kenneth W Dawes?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.